Anthropometric Correlates of Insulin-Like Growth Factor 1 (IGF-1) and IGF Binding Protein-3 (IGFBP-3) Levels by Race/Ethnicity and Gender

Annals of Epidemiology

Volumn 19, Issue 12, 2009, Pages 841-849

  Faupel Badger, Jessica M ^a   Berrigan, David ^a   Ballard Barbash, Rachel ^a   Potischman, Nancy ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

BMI; Cancer; IGF; Obesity

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; CONTROLLED STUDY; ETHNICITY; FEMALE; HUMAN; IMMUNOASSAY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; SEX DIFFERENCE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AFRICAN AMERICANS; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEOPLASMS; NUTRITION SURVEYS; SEX FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 70450149009     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2009.08.005     Document Type: Article

References (52)

1. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. Jama 295 (2006) 1549-1555
2. National Cancer Institute Fact Sheet. Obesity and cancer: questions and answers. Bethesda MNCIM, 2004. http://www.cancer.gov/cancertopics/factsheet/Risk/obesity. NCI fact sheet 3.70. Accessed [6/13/2008].
3. Flegal K.M., Graubard B.I., Williamson D.F., and Gail M.H. Cause-specific excess deaths associated with underweight, overweight, and obesity. Jama 298 (2007) 2028-2037
4. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 (2003) 1625-1638
5. Pan S.Y., and DesMeules M. Energy intake, physical activity, energy balance, and cancer: Epidemiological evidence. In: Verma M. (Ed). Methods of Molecular Biology, Cancer Epidemiology 472 (2009), Humana Press, Totowa, NJ 191-215
6. Pan S.Y., Johnson K.C., Ugnat A.M., Wen S.W., and Mao Y. Association of obesity and cancer risk in Canada. Am J Epidemiol 159 (2004) 259-268
7. Giovannucci E., Liu Y., Platz E.A., Stampfer M.J., and Willett W.C. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 121 (2007) 1571-1578
8. Renehan A.G., Frystyk J., and Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 17 (2006) 328-336
9. Samani A.A., Yakar S., LeRoith D., and Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28 (2007) 20-47
10. Chan J.M., Stampfer M.J., Giovannucci E., Gann P.H., Ma J., Wilkinson P., et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279 (1998) 563-566
11. Chan J.M., Stampfer M.J., Ma J., Gann P., Gaziano J.M., Pollak M., et al. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 94 (2002) 1099-1106
12. Stattin P., Rinaldi S., Stenman U.H., Riboli E., Hallmans G., Bergh A., et al. Plasma prolactin and prostate cancer risk: A prospective study. Int J Cancer 92 (2001) 463-465
13. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131 (2001) 3109S-3120S
14. Ma J., Pollak M., Giovannucci E., Chan J.M., Tao Y., Hennekens C., et al. A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. Growth Horm IGF Res 10 Suppl A (2000) S28-S29
15. Ma J., Pollak M.N., Giovannucci E., Chan J.M., Tao Y., Hennekens C.H., et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91 (1999) 620-625
16. Lukanova A., Lundin E., Toniolo P., Micheli A., Akhmedkhanov A., Rinaldi S., et al. Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer 101 (2002) 549-554
17. Peeters P.H., Lukanova A., Allen N., Berrino F., Key T., Dossus L., et al. Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 14 (2007) 81-90
18. Renehan A.G., Egger M., Minder C., O'Dwyer S.T., Shalet S.M., and Zwahlen M.I.G.F.-I. IGF binding protein-3 and breast cancer risk: comparison of 3 meta-analyses. Int J Cancer 115 (2005) 1006-1007
19. Renehan A.G., Harvie M., and Howell A. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer 13 (2006) 273-278
20. Allen N.E., Appleby P.N., Kaaks R., Rinaldi S., Davey G.K., and Key T.J. Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control 14 (2003) 65-74
21. DeLellis K., Rinaldi S., Kaaks R.J., Kolonel L.N., Henderson B., and Le Marchand L. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 13 (2004) 1444-1451
22. Gapstur S.M., Kopp P., Chiu B.C., Gann P.H., Colangelo L.A., and Liu K. Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in Black and White men: the CARDIA Male Hormone Study. Cancer Epidemiol Biomarkers Prev 13 (2004) 2208-2216
23. Gram I.T., Norat T., Rinaldi S., Dossus L., Lukanova A., Tehard B., et al. Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. Int J Obes (Lond) 30 (2006) 1623-1631
24. Henderson K.D., Goran M.I., Kolonel L.N., Henderson B.E., and Le Marchand L. Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 15 (2006) 2298-2302
25. Lukanova A., Lundin E., Zeleniuch-Jacquotte A., Muti P., Mure A., Rinaldi S., et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol 150 (2004) 161-171
26. Lukanova A., Soderberg S., Stattin P., Palmqvist R., Lundin E., Biessy C., et al. Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden). Cancer Causes Control 13 (2002) 509-516
27. Platz E.A., Pollak M.N., Rimm E.B., Majeed N., Tao Y., Willett W.C., et al. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiol Biomarkers Prev 8 (1999) 1107-1110
28. Berrigan D., Potischman N., Dodd K.W., Hursting S.D., Lavigne J., Barrett J.C., et al. Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults. Growth Horm IGF Res (2008)
29. National Center for Health Statistics. NCHS plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Vital Health Stat (1994) 1
30. National Center for Health Statistics. Analytic and reporting guidelines: the Third National Health and Nutrition Examination Survey, NHANES III (1988-1994). Hyattsville, MD, 1996.
31. Berrigan D., Potischman N., Dodd K.W., Nicar M., McQuillan G., Lavigne J.A., et al. Serum levels of insulin-like growth factor-1 and insulin like growth factor-1 binding protein-3: Quality control for studies of stored serum. Cancer Epidemiol Biomarkers Prev 16 (2007) 1017-1022
32. Chumlea W.C., Guo S.S., Kuczmarski R.J., Flegal K.M., Johnson C.L., Heymsfield S.B., et al. Body composition estimates from NHANES III bioelectrical impedance data. Int J Obes Relat Metab Disord 26 (2002) 1596-1609
33. Shah B.V., Barnwell G., and Bieler G.S. SUDAAN user's manual, release 8.0 (1997), Research Triangle Institute, Research Triangle Park, NC
34. Korn E.L., and Graubard B.I. Analysis of health surveys (1999), John Wiley and Sons, New York
35. Holmes M.D., Pollak M.N., and Hankinson S.E. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11 (2002) 862-867
36. Chang S., Wu X., Yu H., and Spitz M.R. Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. Cancer Epidemiol Biomarkers Prev 11 (2002) 758-766
37. Kaaks R., and Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60 (2001) 91-106
38. Gunter M.J., Hoover D.R., Yu H., Wassertheil-Smoller S., Manson J.E., Li J., et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev 17 (2008) 921-929
39. Gunter M.J., Hoover D.R., Yu H., Wassertheil-Smoller S., Rohan T.E., Manson J.E., et al. Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res 68 (2008) 329-337
40. Calle E.E., and Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4 (2004) 579-591
41. Frystyk J. Utility of free IGF-I measurements. Pituitary 10 (2007) 181-187
42. Frystyk J. Free insulin-like growth factors-measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 14 (2004) 337-375
43. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 337-342
44. Hursting S.D., Nunez N.P., Varticovski L., and Vinson C. The obesity-cancer link: lessons learned from a fatless mouse. Cancer Res 67 (2007) 2391-2393
45. Yakar S., Nunez N.P., Pennisi P., Brodt P., Sun H., Fallavollita L., et al. Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology 147 (2006) 5826-5834
46. Berrigan D., Perkins S.N., Haines D.C., and Hursting S.D. Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23 (2002) 817-822
47. Hursting S.D., Lashinger L.M., Wheatley K.W., Rogers C.J., Colbert L.H., Nunez N.P., et al. Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link. Best Pract Res Clin Endocrinol Metab 22 (2008) 659-669
48. American Cancer Society. Cancer Facts and Figures 2008 (2008), American Cancer Society, Altanta
49. Allen N.E., Roddam A.W., Allen D.S., Fentiman I.S., Dos Santos Silva I., Peto J., et al. A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer 92 (2005) 1283-1287
50. Giovannucci E., Pollak M.N., Platz E.A., Willett W.C., Stampfer M.J., Majeed N., et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9 (2000) 345-349
51. Renehan A.G., Zwahlen M., Minder C., O'Dwyer S.T., Shalet S.M., and Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363 (2004) 1346-1353
52. Stattin P., Bylund A., Rinaldi S., Biessy C., Dechaud H., Stenman U.H., et al. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92 (2000) 1910-1917